
Edwards Lifesciences Corp
NYSE:EW

Intrinsic Value
The intrinsic value of one
EW
stock under the Base Case scenario is
53.61
USD.
Compared to the current market price of 71.53 USD,
Edwards Lifesciences Corp
is
Overvalued by 25%.
The Intrinsic Value is calculated as the average of DCF and Relative values:

Valuation History
Edwards Lifesciences Corp
Fundamental Analysis

Edwards Lifesciences depends heavily on its TAVR franchise, making any slowdown in procedural volumes or tighter site-of-service regulations a significant risk to its top line growth.
Edwards Lifesciences holds a leadership position in TAVR technology, particularly with its SAPIEN platform, which remains the gold standard for many heart centers worldwide and drives robust revenue growth.

Revenue & Expenses Breakdown
Edwards Lifesciences Corp
Balance Sheet Decomposition
Edwards Lifesciences Corp
Current Assets | 6.3B |
Cash & Short-Term Investments | 4B |
Receivables | 727.4m |
Other Current Assets | 1.6B |
Non-Current Assets | 6.8B |
Long-Term Investments | 307.9m |
PP&E | 1.8B |
Intangibles | 3B |
Other Non-Current Assets | 1.7B |
Free Cash Flow Analysis
Edwards Lifesciences Corp
USD | |
Free Cash Flow | USD |
Earnings Waterfall
Edwards Lifesciences Corp
Revenue
|
5.4B
USD
|
Cost of Revenue
|
-1.1B
USD
|
Gross Profit
|
4.3B
USD
|
Operating Expenses
|
-2.8B
USD
|
Operating Income
|
1.5B
USD
|
Other Expenses
|
2.7B
USD
|
Net Income
|
4.2B
USD
|
EW Profitability Score
Profitability Due Diligence
Edwards Lifesciences Corp's profitability score is 72/100. The higher the profitability score, the more profitable the company is.

Score
Edwards Lifesciences Corp's profitability score is 72/100. The higher the profitability score, the more profitable the company is.
EW Solvency Score
Solvency Due Diligence
Edwards Lifesciences Corp's solvency score is 99/100. The higher the solvency score, the more solvent the company is.

Score
Edwards Lifesciences Corp's solvency score is 99/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
EW Price Targets Summary
Edwards Lifesciences Corp
According to Wall Street analysts, the average 1-year price target for
EW
is 81.16 USD
with a low forecast of 61.61 USD and a high forecast of 94.5 USD.
Dividends
Current shareholder yield for EW is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one
EW
stock under the Base Case scenario is
53.61
USD.
Compared to the current market price of 71.53 USD,
Edwards Lifesciences Corp
is
Overvalued by 25%.